Creatine kinase increases in adults with uncontrolled hypertension
Main Article Content
Abstract
Article Details
Issue
Section
The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.
How to Cite
References
Blumenfeld JD, Liu F, Laragh JH. Primary and
secondary hypertension. In: Brenner and the
rector‘s the kidney. 9th ed. Philadelphia: Elsevier-
Saunders;2012.p.1670-751.
Egan BM, Zhao Y, Axon RN. US trends in
prevalence, awareness, treatment, and control of
hypertension, 1998-2008. JAMA 2010;303:
-50.
Olives C, Myerson R, Mokdad AH, Murray CJL,
Lim SS. Prevalence, awareness, treatment, and
control of hypertension in United States counties,
-2009. PLoS ONE 2013;8:e60308.
Egan BM, Zhao Y, Axon RN, Brzezinski WA,
Ferdinand KC. Uncontrolled and apparent
treatment-resistant hypertension in the United
States, 1998 to 2008. Circulation 2011;124:1046-
Brewster LM, van Montfrans GA, Kleijnen J.
Systematic review: anti-hypertensive drug
therapy in black patients. Ann Intern Med 2004;
:614-27.
Gu Q, Dillon CF, Burt VL, Gillu RF. Association
of hypertension treatment and control with allcause
and cardiovascular disease mortality
among US adults with hypertension. Am J
Hypertens 2010;23:38-45.
Oudman I. Creatine kinase and blood pressure:
clinical and therapeutic implications
[dissertation]. Amsterdam: University of
Amsterdam;2013. Available at: http://dare.uva.nl
/record/ 441526. Accessed September 1, 2013.
Brewster LM, Mairuhu G, Bindraban NR,
Koopmans RP, Clark JF, van Montfrans GA.
Creatine kinase activity is associated with blood
pressure. Circulation 2006;114:2034-9.
Oudman I, Preschana V, Kewalbansingh, van
Valkengoed I, Zwinderman AH, Clark JF, et al.
Creatine kinase is associated with failure of
hypertension treatment. J Hypertens 2013;31:
-31.
Brewster LM, Coronel CMD, Sluiter W, Clark
JF, van Montfrans GA. Ethnic differences in
tissue creatine kinase activity: an observational
study. PLoS ONE 2012;7:e32471.
Chobanian AV, Bakris GL, Black HR, Cushman
WC, Green LA, Izzo JL, et al. and the National
High Blood Pressure Education Program
Coordinating Committee. Seventh report of the
Joint National Committee on prevention,
detection, evaluation, and treatment of high
blood pressure. Hypertension 2003;42:1206-52.
Sastroasmoro S, Ismael S. Dasar-dasar
metodologi penelitian klinis. 4th ed. Jakarta:
Sagung Seto; 2011.
Savoldelli VK, Gillaizeau F, Pouchot J, Lenain
E, Vinay NP, Plouin PF, et al. Validation of
French version of the 8-item Morisky medication
adherence scale in hypertensive adults. J Clin
Hypertens 2012;14:429-34.
Brewster LM, van Bree S, Reijneveld JC,
Notermans NC, Verschuren WMM, Clark JF, et
al. Hypertension risk in idiopathic hyperCKemia.
J Neurol 2008;255:11-5.
Johnsen SH, Lilleng H, Wilsgaard T, Bekkelund
SI. Creatine kinase activity and blood pressure
in a normal population: the Tromso study. J
Hypertens 2010;29:36-42.
Brewster LM, Mairuhu G, Ganzeboom K, van
Dijk N, van Montfrans GA, Wieling W. Low
creatine kinase is associated with a high
population incidence of fainting. Clin Auton Res
;19:231-6.
Beevers G, Lip GYH, Brien EO. ABC of
hypertension: the pathophysiology of
hypertension. BMJ 2001;322:912-6.
Brewster LM, Clark JF, van Montfrans GA. Is
greater tissue activity of creatine kinase the
genetic factor increasing hypertension risk in
black people of sub-Saharan African descent?. J
Hypertens 2000;18:1537-44.